ACM
XERS icon

Aster Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Aster Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.77K Buy
+687
New +$4.55K ﹤0.01% 703
2025
Q3 		– Sell
-1,067
Closed -$4.98K – 1416
2025
Q2 		$4.98K Buy
+1,067
New +$4.89K ﹤0.01% 863

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aster Capital Management's XERS Position: Q1 2026 in Review

Aster Capital Management opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 687 shares worth $3.77K. The stake represents ﹤0.01% of the portfolio and ranks #703 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in XERS as recently as Q2 2025.

Aster Capital Management first reported a position in XERS in Q2 2025 and has held it in 2 quarters since. The position peaked at $4.98K in Q2 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Aster Capital Management held 687 shares of Xeris Biopharma Holdings worth $3.77K as of Q1 2026.
  • Xeris Biopharma Holdings was a new Aster Capital Management position in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #703 holding.
  • Aster Capital Management first reported a position in Xeris Biopharma Holdings in Q2 2025 and has held it in 2 quarters since.
  • Aster Capital Management's Xeris Biopharma Holdings position peaked at $4.98K in Q2 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.